0001816590-24-000016.txt : 20240123 0001816590-24-000016.hdr.sgml : 20240123 20240123175412 ACCESSION NUMBER: 0001816590-24-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240119 FILED AS OF DATE: 20240123 DATE AS OF CHANGE: 20240123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goldsmith George Jay CENTRAL INDEX KEY: 0001843859 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39522 FILM NUMBER: 24553724 MAIL ADDRESS: STREET 1: C/O COMPASS PATHWAYS PLC STREET 2: 1 ASHLEY ROAD, 3RD FLOOR, ALTRINCHAM CITY: CHESHIRE STATE: X0 ZIP: WA14 2DT ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COMPASS Pathways plc CENTRAL INDEX KEY: 0001816590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3RD FLOOR, 1 ASHLEY ROAD STREET 2: ALTRINCHAM CITY: CHESIRE STATE: X0 ZIP: WA14 2DT BUSINESS PHONE: 1-716-676-6461 MAIL ADDRESS: STREET 1: 3RD FLOOR, 1 ASHLEY ROAD STREET 2: ALTRINCHAM CITY: CHESIRE STATE: X0 ZIP: WA14 2DT FORMER COMPANY: FORMER CONFORMED NAME: Compass Rx Ltd. DATE OF NAME CHANGE: 20200701 4 1 wk-form4_1706050433.xml FORM 4 X0508 4 2024-01-19 0 0001816590 COMPASS Pathways plc CMPS 0001843859 Goldsmith George Jay COMPASS PATHWAYS PLC 33 BROADWICK STREET LONDON X0 W1F 0DQ UNITED KINGDOM 1 0 1 0 1 Ordinary Shares 2024-01-19 4 S 0 20205 7.9901 D 4198154 D Ordinary Shares 2024-01-19 4 S 0 20206 7.9901 D 4195495 I By: Spouse Ordinary Shares 2024-01-22 4 S 0 25750 8.3508 D 4172404 D Ordinary Shares 2024-01-22 4 S 0 25750 8.3508 D 4169745 I By: Spouse The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Mr. Goldsmith on August 23, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.78 to $8.18, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Dr. Malievskaia on August 23, 2023. Securities held by Dr. Ekaterina Malievskaia, the Reporting Person's spouse. Dr. Malievskaia and Mr. Goldsmith are married but they expressly disclaim beneficial ownership of each other's shares in the Issuer. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.92 to $8.55, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. /s/ Meredith Prithviraj by Power-of-Attorney for George Jay Goldsmith 2024-01-23